Raymond James & Associates’s Morgan Stanley Emerging Mkts Fd MSF Stock Holding History
Bought
Maintained
Sold
Other funds holding MSF
Raymond James & Associates's MSF Position: Q1 2019 in Review
Raymond James & Associates sold out of Morgan Stanley Emerging Mkts Fd (MSF) in Q1 2019, closing a stake of 77,755 shares — an estimated $1.25M sold.
Raymond James & Associates first reported a position in MSF in Q2 2015 and held it in 13 quarters. The position peaked at $1.3M in Q2 2018. 1 fund tracked by Wall St. Rank holds MSF as of Q1 2019.
- Raymond James & Associates reported no remaining Morgan Stanley Emerging Mkts Fd position as of Q1 2019 after selling out during the quarter.
- Raymond James & Associates sold 77,755 Morgan Stanley Emerging Mkts Fd shares in Q1 2019, an estimated $1.25M.
- Raymond James & Associates first reported a position in Morgan Stanley Emerging Mkts Fd in Q2 2015 and held it in 13 quarters.
- Raymond James & Associates's Morgan Stanley Emerging Mkts Fd position peaked at $1.3M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Morgan Stanley Emerging Mkts Fd as of Q1 2019.
Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.